Adaptimmune Therapeutics shares owned by Hsbc Holdings
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Hsbc Holdings
from 13F filings
Historical chart of Hsbc Holdings investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Hsbc Holdings
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $5.2k | 26k | 0.20 |
| 2024-12-31 | $14k | 26k | 0.55 |
| 2024-09-30 | $25k | 26k | 0.94 |
| 2024-06-30 | $26k | 26k | 0.99 |
| 2024-03-31 | $41k | 26k | 1.58 |
| 2023-12-31 | $19k | 27k | 0.71 |
| 2023-09-30 | $20k | 26k | 0.77 |
| 2023-06-30 | $24k | 26k | 0.92 |